MedPath
NMPA Approval

Valsartan and Amlodipine Tablets(I)

国药准字H20253793

April 1, 2025

Drug Information

缬沙坦氨氯地平片(Ⅰ)

片剂

每片含缬沙坦80mg,氨氯地平5mg

化学药品

April 1, 2025

Company Information

Applicant Company

沧州经济技术开发区北海路10号

Manufacturing Company

沧州经济技术开发区北海路10号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

缬沙坦氨氯地平片(Ⅰ) - NMPA 批准文号 | MedPath